Novo Holdings tjente 19,1 mia. kr. i 2017

Novo Holdings, der blandt andet ejer Novo Nordisk, landede et overskud på 19,1 mia. kr. i 2017. Det skete i et år, hvor selskabets life science-investeringer uden for Novo-gruppen gav et afkast på 24 pct.

Novo Holdings, investeringsselskabet bag blandt andet Novo Nordisk, ejes selv af Novo Nordisk Fonden - det øverste selskab i Novo-organisationen. | Photo: Martin Havtorn Petersen/MedWatch

Pengene vælter ind hos Novo Holdings, som ejer Novo Nordisk, Novozymes, Novo Seeds, Novo Ventures og meget andet. Det står klart, efter at selskabet har offentliggjort sine regnskabstal for 2017.

Selskabet tjente 19,1 mia. kr. i 2017 mod 7,1 mia. kr. året før.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Savills IM working hard on first Nordic residential investment

The global property investor has plans to expand its growing portfolio in Denmark with a new asset class, residential real estate, "very soon," says Head of Nordics Peter Broström. The manager still believes in the office and retail sectors, despite the pandemic and rising inflation.

Latest news


Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch